methoxamine has been researched along with Electrocardiogram QT Prolonged in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, B; Carlsson, L; Linhardt, G; Löfberg, L | 1 |
| Ajiki, K; Hayami, N; Inaba, H; Kunishima, T; Mikamo, T; Murakawa, Y; Sugiura, A; Tsutsui, K; Watanabe, H; Yamagishi, N; Yamagishi, S | 1 |
| Aller, MI; Daut, J; Decher, N; Kaufmann, SG; Li, XT; Maier, SK; Meuth, SG; Netter, MF; Rinné, S; Sachse, FB; Wemhöner, K; Zuzarte, M | 1 |
| Ajiki, K; Hayami, N; Kanamori, K; Kunishima, T; Mikamo, T; Murakawa, Y; Sugiura, A; Tsutsui, K; Watanabe, H; Yamagishi, N; Yamagishi, S | 1 |
| Hirasaki, S; Hyogo, M; Ishibashi, K; Keira, N; Nakagawa, M; Shiraishi, H; Shirayama, T; Tsukamoto, M; Urao, N | 1 |
| Carlsson, L | 1 |
| Hasumi, H; Hata, Y; Kaneko, N; Matsuda, R; Shimamoto, K | 1 |
| Dai, DZ; Dai, Y; Huang, ZJ; Ji, M; Li, N; Na, T | 1 |
| Kamiya, T; Kawade, M; Ohe, T | 1 |
| Abrahamsson, C; Andersson, B; Carlsson, L; Duker, G; Schiller-Linhardt, G | 1 |
| Anderson, ME; Mazur, A; Roden, DM | 1 |
| De Clerck, F; Lu, HR; Remeysen, P; Saels, A; Somers, K | 1 |
1 review(s) available for methoxamine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
In vitro and in vivo models for testing arrhythmogenesis in drugs.
Topics: Adrenergic alpha-Agonists; Animals; Cats; Disease Models, Animal; Dogs; Drug-Related Side Effects and Adverse Reactions; Guinea Pigs; Heart; Heart Block; Heart Ventricles; Long QT Syndrome; Methoxamine; Rabbits; Torsades de Pointes | 2006 |
11 other study(ies) available for methoxamine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Long QT Syndrome; Male; Methoxamine; Phenethylamines; Potassium Channel Blockers; Rabbits; Sulfonamides; Time Factors | 2009 |
Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, General; Anesthetics, Combined; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Ketamine; Long QT Syndrome; Male; Methoxamine; Pyrimidinones; Rabbits; Tachycardia, Ventricular; Time Factors; Xylazine | 2011 |
Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Electrophysiological Phenomena; Heart Rate; Hemodynamics; Isoflurane; Long QT Syndrome; Methoxamine; Mice; Mice, Knockout; Myocytes, Cardiac; Nerve Tissue Proteins; ortho-Aminobenzoates; Potassium Channels, Tandem Pore Domain; Sulfonamides | 2011 |
Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Clonidine; Dexmedetomidine; Disease Models, Animal; Heart Conduction System; Humans; Long QT Syndrome; Methoxamine; Pyrimidinones; Rabbits; Tachycardia | 2012 |
Idiopathic long QT syndrome with early afterdepolarization induced by epinephrine. Acase report.
Topics: Adrenergic alpha-Agonists; Electrocardiography; Epinephrine; Female; Humans; Long QT Syndrome; Membrane Potentials; Methoxamine; Middle Aged; Pedigree | 2004 |
K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Heart Rate; Long QT Syndrome; Male; Methoxamine; Potassium Channel Blockers; Quaternary Ammonium Compounds; Rabbits; Sodium Channel Blockers; Thiazepines; Torsades de Pointes | 2007 |
Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
Topics: Algorithms; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Electrocardiography; Female; Guinea Pigs; Heart Rate; Long QT Syndrome; Male; Membrane Potentials; Methoxamine; Molecular Structure; Myocardial Contraction; Myocytes, Cardiac; Naphthalenes; Phenethylamines; Potassium Channels, Inwardly Rectifying; Rabbits; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sulfonamides; Torsades de Pointes | 2007 |
Provocative testing and drug response in a patient with the long QT syndrome.
Topics: Adolescent; Drug Therapy, Combination; Electrocardiography; Epinephrine; Female; Humans; Isoproterenol; Long QT Syndrome; Methoxamine; Propranolol; Torsades de Pointes; Verapamil | 1995 |
Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cats; Drug Administration Schedule; Electrophysiology; Heart; Infusions, Intravenous; Long QT Syndrome; Male; Methoxamine; Propanolamines; Purkinje Fibers; Rabbits; Torsades de Pointes | 1993 |
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Heart Rate; Isoquinolines; Long QT Syndrome; Male; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sulfonamides; Torsades de Pointes | 1999 |
Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Incidence; Long QT Syndrome; Male; Methoxamine; Models, Cardiovascular; Phenethylamines; Rabbits; Receptors, Adrenergic, alpha-1; Risk Factors; Sex Factors; Sulfonamides; Treatment Outcome; Women's Health | 2001 |